All Deals
July 20, 2026 - Deals
Neo Secures $100 Million Funding Led By Andreessen Horowitz And Bessemer Venture Partners
Neo, a Boston-based cybersecurity startup focused on securing AI agents and agentic software, has emerged from stealth with $100 million in total funding, including a $75 million Series A led by Andreessen Horowitz and Bessemer Venture Partners, alongside participation from Craft Ventures and Merlin Ventures, following a previously undisclosed $25 million seed round. Founded by Nick Warner, Shlomi Salem, and Eran Shirazi, Neo provides SecOps teams with real-time inventory, risk intelligence, attribution, and policy controls to govern AI agents operating across enterprise environments. The company plans to use the funding to expand its engineering and go-to-market teams as demand grows for tools that help organizations manage the security risks posed by increasingly autonomous AI systems.
FOUNDERS: Nick Warner, Shlomi Salem & Eran Shirazi
INVESTORS: Andreessen Horowitz, Bessemer Venture Partners, Craft Ventures & Merlin Ventures
ROUND: Seed + Series A
AMOUNT: $100,000,000
HQ: Boston, Massachusetts
#VentureCapital #Neo #TradedPartner #AndreessenHorowitz #TradedVC
More Deals
View AllColossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC